ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 172 filers reported holding ZAI LAB LTD in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $94,282 | -76.7% | 3,400 | -72.1% | 0.00% | -100.0% |
| Q1 2023 | $404,774 | +50.3% | 12,170 | +38.8% | 0.00% | 0.0% |
| Q4 2022 | $269,239 | -10.3% | 8,770 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $300,000 | +22.0% | 8,770 | +23.7% | 0.00% | 0.0% |
| Q2 2022 | $246,000 | -21.2% | 7,090 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $312,000 | -8.5% | 7,090 | +30.8% | 0.00% | 0.0% |
| Q4 2021 | $341,000 | -40.3% | 5,420 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $571,000 | -40.5% | 5,420 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $959,000 | +48.0% | 5,420 | +11.5% | 0.01% | +50.0% |
| Q1 2021 | $648,000 | -1.5% | 4,860 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $658,000 | +135.0% | 4,860 | +44.2% | 0.00% | +100.0% |
| Q3 2020 | $280,000 | +1.1% | 3,370 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $277,000 | – | 3,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 106,171 | $2,938 | 14.16% |
| Genesis Investment Management, LLP | 1,352,222 | $37,420,559 | 4.06% |
| Segantii Capital Management Ltd | 1,795,479 | $49,788,633 | 2.59% |
| HSG Holding Ltd | 694,634 | $19,262,201 | 2.20% |
| Paradigm Biocapital Advisors LP | 865,297 | $23,994,686 | 1.85% |
| INDUS CAPITAL PARTNERS, LLC | 25,256 | $700,349 | 1.41% |
| Privium Fund Management B.V. | 240,683 | $6,366,065 | 1.34% |
| Vivo Capital, LLC | 445,505 | $12,353,854 | 0.85% |
| Rock Springs Capital Management LP | 1,222,423 | $33,897,790 | 0.81% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $2,189,505 | 0.67% |